DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2Dr. Reddy's Laboratories
02 1Shandong Loncom Pharmaceutical
03 1Alembic Pharmaceuticals Limited
04 1Beijing Mesochem Technology
05 1Chongqing Carelife Pharmaceutical
06 1Guangzhou Tosun Pharmaceutical
07 1Hetero Drugs
08 2MSN Laboratories
09 1Mac-Chem Products (India) Pvt.Ltd
10 1Natco Pharma
11 2Olon S.p.A
12 1Parsian Pharamceutical
13 1Shanghai Hope Chem
14 1Shilpa Medicare
15 1Sichuan Qingmu Pharmaceutical
16 1Sun Pharmaceutical Industries Limited
17 1Vannsh Life Sciences
18 1Yangtze River Pharmaceutical Group
01 7China
02 11India
03 1Iran
04 2Italy
01 10Active
02 11Blank
01 21Blank
01 21Blank
01 1WC-0039
02 1WC-0067
03 1WC-0349
04 1WC-0349A5-A6
05 1WC-0372
06 16Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-10-24
Pay. Date : 2018-08-09
DMF Number : 32905
Submission : 2018-06-26
Status : Active
Type : II
Date of Issue : 2022-06-06
Valid Till : 2025-07-07
Written Confirmation Number : WC-0039
Address of the Firm :
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-11-30
Pay. Date : 2021-11-08
DMF Number : 36031
Submission : 2021-06-30
Status : Active
Type : II
Date of Issue : 2022-06-17
Valid Till : 2025-07-07
Written Confirmation Number : WC-0067
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33964
Submission : 2019-06-27
Status : Active
Type : II
NDC Package Code : 17337-0099
Start Marketing Date : 2021-10-05
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37347
Submission : 2022-07-28
Status : Active
Type : II
NDC Package Code : 17337-0099
Start Marketing Date : 2021-10-05
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-11-20
Pay. Date : 2018-09-04
DMF Number : 33083
Submission : 2018-09-04
Status : Active
Type : II
NDC Package Code : 82920-036
Start Marketing Date : 2022-08-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39887
Submission : 2024-04-30
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-01-24
Pay. Date : 2021-12-16
DMF Number : 36197
Submission : 2021-12-22
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-03-27
Pay. Date : 2018-12-12
DMF Number : 33331
Submission : 2019-02-04
Status : Active
Type : II
Date of Issue : 2019-10-07
Valid Till : 2022-06-12
Written Confirmation Number : WC-0372
Address of the Firm :
We have 18 companies offering Lenvatinib Mesylate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?